BRIEF published on 09/19/2024 at 07:35, 1 year 9 months ago Viridien Selected for Technology-Driven Mineral Exploration Program in Oman Mineral Exploration AI Technology Remote Sensing Geoscience Oman Mining
BRIEF published on 09/19/2024 at 07:35, 1 year 9 months ago Viridien sélectionné pour un programme d'exploration minière axé sur la technologie à Oman Exploration Minière Géosciences Technologie De L'IA Télédétection Exploitation Minière À Oman
BRIEF published on 09/19/2024 at 07:20, 1 year 9 months ago Tonner Drones convoque son assemblée générale et élargit sa stratégie Stratégie Rentabilité Assemblée Générale Reorganisation Administrateurs
BRIEF published on 09/19/2024 at 07:20, 1 year 9 months ago Tonner Drones convenes its general meeting and expands its strategy Profitability Reorganization General Meeting Strategy Administrators
BRIEF published on 09/19/2024 at 07:05, 1 year 9 months ago Xlife Sciences AG: Successful First Half of 2024 with Strategic Progress and Solid Financial Figures Strategic Partnerships Financial Performance Life Sciences Xlife Sciences 2024 Half-Year Report
BRIEF published on 09/19/2024 at 07:05, 1 year 9 months ago Xlife Sciences AG : Premier semestre 2024 réussi avec des progrès stratégiques et des chiffres financiers solides Partenariats Stratégiques Performance Financière Sciences De La Vie Rapport Semestriel 2024 Sciences De La Vie X
BRIEF published on 09/19/2024 at 07:05, 1 year 9 months ago AEVIS VICTORIA SA Reports Strong Half-Year 2024 Results Revenue Growth Healthcare Half-year Results Hospitality AEVIS VICTORIA
BRIEF published on 09/19/2024 at 07:05, 1 year 9 months ago AEVIS VICTORIA SA publie de solides résultats pour le premier semestre 2024 Résultats Semestriels Croissance Des Revenus Soins De Santé Hospitalité AEVIS VICTORIA
BRIEF published on 09/19/2024 at 07:05, 1 year 9 months ago Newron Pharmaceuticals Presents H1 2024 Results and Business Update Clinical Trials Newron Pharmaceuticals Evenamide Schizophrenia Treatment H1 2024
BRIEF published on 09/19/2024 at 07:05, 1 year 9 months ago Newron Pharmaceuticals présente ses résultats du premier semestre 2024 et son point sur ses activités Essais Cliniques Evenamide Traitement De La Schizophrénie Premier Semestre 2024 Newron Pharmaceutique
Published on 06/27/2026 at 16:50, 1 day 1 hour ago Redwood AI Announces Definitive Agreement with Quantum.IQ and Expands into Quantum Resistant Cyber Security
Published on 06/27/2026 at 01:40, 1 day 16 hours ago Polaris Renewable Energy Announces Results of Director Elections at Annual and Special Meeting
Published on 06/27/2026 at 00:00, 1 day 18 hours ago Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
Published on 06/26/2026 at 23:00, 1 day 19 hours ago Canadian North Resources Inc. Announces Results of 2026 Annual General and Special Shareholders Meeting
Published on 06/26/2026 at 22:50, 1 day 19 hours ago Banyan Gold Files Technical Report for AurMac Project, Yukon, Canada
Published on 06/28/2026 at 17:26, 45 minutes ago EQS-Adhoc: Correction of a release from 24/06/2026, 20:54 CET/CEST - Branicks Group AG sets out timetable for the publication of its 2025 annual and consolidated financial statements
Published on 06/27/2026 at 00:05, 1 day 18 hours ago EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss
Published on 06/27/2026 at 00:04, 1 day 18 hours ago Persistent and Nagarro sign Business Combination Agreement to form the Persistent - Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 1 day 18 hours ago Persistent and Nagarro sign Business Combination Agreement to form the Persistent – Nagarro Group, a global leader in AI-led digital engineering
Published on 06/26/2026 at 23:36, 1 day 18 hours ago EQS-Adhoc: Nagarro SE: Nagarro signs business combination agreement with Persistent Systems and supports voluntary public takeover offer to all shareholders at EUR 81 per share
